[HTML][HTML] Biomarkers in heart failure: From research to clinical practice
AE Berezin, AA Berezin - Annals of laboratory medicine, 2023 - synapse.koreamed.org
The aim of this narrative review is to summarize contemporary evidence on the use of
circulating cardiac biomarkers of heart failure (HF) and to identify a promising biomarker …
circulating cardiac biomarkers of heart failure (HF) and to identify a promising biomarker …
Cardiac biomarkers and their role in identifying increased risk of cardiovascular complications in COVID-19 patients
N Yaluri, A Stančáková Yaluri, P Žeňuch, Z Žeňuchová… - Diagnostics, 2023 - mdpi.com
Cardiovascular disease (CVD) is a global health concern, causing significant morbidity and
mortality. Both lifestyle and genetics influence the development of CVD. It is often diagnosed …
mortality. Both lifestyle and genetics influence the development of CVD. It is often diagnosed …
PPAR alpha activation by clofibrate alleviates ischemia/reperfusion injury in metabolic syndrome rats by decreasing cardiac inflammation and remodeling and by …
M Sánchez-Aguilar, L Ibarra-Lara… - International Journal of …, 2023 - mdpi.com
Metabolic syndrome (MetS) is a cluster of factors that increase the risk of developing
diabetes, stroke, and heart failure. The pathophysiology of injury by ischemia/reperfusion …
diabetes, stroke, and heart failure. The pathophysiology of injury by ischemia/reperfusion …
Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment
R Lasica, L Djukanovic, L Savic, G Krljanac… - Diagnostics, 2023 - mdpi.com
Although the frequency of myocarditis in the general population is very difficult to accurately
determine due to the large number of asymptomatic cases, the incidence of this disease is …
determine due to the large number of asymptomatic cases, the incidence of this disease is …
Non-alcoholic fatty liver disease and bone tissue metabolism: current findings and future perspectives
OM Drapkina, AY Elkina, AF Sheptulina… - International Journal of …, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is reaching epidemic proportions worldwide.
Moreover, the prevalence of this liver disease is expected to increase rapidly in the near …
Moreover, the prevalence of this liver disease is expected to increase rapidly in the near …
Cardioprotective Effect of Hydroalcohol Extract of Andaliman (Zanthoxylum acanthopodium DC.) Fruits on Doxorubicin-Induced Rats
Andaliman (Zanthoxylum acanthopodium DC.) fruit is a spice plant widely used in North
Sumatra. The chemical content in the Andaliman plant has a cardioprotective effect, with …
Sumatra. The chemical content in the Andaliman plant has a cardioprotective effect, with …
Microfluidic-based cardiovascular systems for advanced study of atherosclerosis
H Zheng, L Tai, C Xu, W Wang, Q Ma… - Journal of Materials …, 2024 - pubs.rsc.org
Atherosclerosis (AS) is a significant global health concern due to its high morbidity and
mortality rates. Extensive efforts have been made to replicate the cardiovascular system and …
mortality rates. Extensive efforts have been made to replicate the cardiovascular system and …
Curcumin mitigates gentamicin induced-renal and cardiac toxicity via modulation of Keap1/Nrf2, NF-κB/iNOS and Bcl-2/BAX pathways
Gentamicin (GEN) is an aminoglycoside antibiotic used to treat gram-negative bacterial
infections. Our study aimed to explore curcumin's (CMN) protective role against GEN …
infections. Our study aimed to explore curcumin's (CMN) protective role against GEN …
Blood-based HYAL2 methylation as a potential marker for the preclinical detection of coronary heart disease and stroke
L Bi, J Jin, Y Fan, Y Liu, H Xu, M Li, C Chen, C Shen… - Clinical …, 2024 - Springer
Background Coronary heart disease (CHD) and stroke have become the leading cause of
premature mortality and morbidity worldwide. Therefore, sensitive and accurate biomarkers …
premature mortality and morbidity worldwide. Therefore, sensitive and accurate biomarkers …
Developing a novel immune-related seven-gene signature and immune infiltration pattern in patients with COVID-19 and cardiovascular disease
Y Fu, J Zhang, L Xu, H Zhang, S Ma, Y Gao… - Journal of …, 2022 - mdpi.com
Background: patients with pre-existence of cardiovascular disease (CVD) are vulnerable to
coronavirus disease 2019 (COVID-19), and COVID-19 will cause long-term burden of CVD …
coronavirus disease 2019 (COVID-19), and COVID-19 will cause long-term burden of CVD …